Сорафениб Зентива

Сорафениб Зентива (sorafenib tosylate) is an oral prescription medication used in cancer treatment. It belongs to the kinase inhibitor class and is manufactured by Zentiva. This EU-origin product is taken by mouth to support targeted therapy approaches.

Sorafenib tosylate is primarily used to treat certain types of cancer, including advanced renal cell carcinoma and hepatocellular carcinoma. It is also prescribed for differentiated thyroid carcinoma that has progressed despite radioactive iodine therapy. Patients and caregivers often ask what sorafenib tosylate is used for when discussing treatment options with healthcare providers.

As a kinase inhibitor, sorafenib tosylate works by helping to slow or stop the growth of cancer cells. Many patients notice it is taken as part of a broader treatment plan. Common effects may include fatigue, skin reactions, or digestive changes during therapy. These responses vary widely among individuals.

Sorafenib tosylate should be handled with care and used only under medical supervision. Patients are advised to report any unusual symptoms to their doctor promptly. It is important to follow all handling and storage instructions provided with the medication. Keep this product out of reach of children and pets.

Sorafenib tosylate may interact with other medications, including strong CYP3A4 inhibitors or inducers, which can affect how it works. Alcohol and certain herbal supplements may also alter its effects. Always inform your healthcare provider about all drugs and supplements you are taking before starting sorafenib tosylate.